97 related articles for article (PubMed ID: 2903710)
21. Designer genes and anti-anxiety drugs.
Tecott LH
Nat Neurosci; 2000 Jun; 3(6):529-30. PubMed ID: 10816304
[No Abstract] [Full Text] [Related]
22. Anxiolytic-like actions of the hexane extract from leaves of Annona cherimolia in two anxiety paradigms: possible involvement of the GABA/benzodiazepine receptor complex.
López-Rubalcava C; Piña-Medina B; Estrada-Reyes R; Heinze G; Martínez-Vázquez M
Life Sci; 2006 Jan; 78(7):730-7. PubMed ID: 16122763
[TBL] [Abstract][Full Text] [Related]
23. Differences between BDZ1 selective and non-selective GABAA/BDZ receptor ligands in discriminative stimulus and EtOH intake/preference paradigms.
Iwinska K; Jankowska E; Stefanski R; Bienkowski P; Kostowski W
Acta Physiol Hung; 1996; 84(4):417-8. PubMed ID: 9328618
[No Abstract] [Full Text] [Related]
24. The value of genetic and pharmacological approaches to understanding the complexities of GABA(A) receptor subtype functions: the anxiolytic effects of benzodiazepines.
Reynolds DS
Pharmacol Biochem Behav; 2008 Jul; 90(1):37-42. PubMed ID: 18457867
[TBL] [Abstract][Full Text] [Related]
25. Effects of the benzodiazepine receptor inverse agonist, DMCM, on the behaviour of mice: an ethopharmacological study.
Cutler MG; Aitken CC
Neuropharmacology; 1991 Dec; 30(12A):1255-61. PubMed ID: 1664917
[TBL] [Abstract][Full Text] [Related]
26. New anxiolytics in development.
Mosconi M; Chiamulera C; Recchia G
Int J Clin Pharmacol Res; 1993; 13(6):331-44. PubMed ID: 7916335
[TBL] [Abstract][Full Text] [Related]
27. SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.
Griebel G; Perrault G; Simiand J; Cohen C; Granger P; Decobert M; Françon D; Avenet P; Depoortere H; Tan S; Oblin A; Schoemaker H; Evanno Y; Sevrin M; George P; Scatton B
J Pharmacol Exp Ther; 2001 Aug; 298(2):753-68. PubMed ID: 11454940
[TBL] [Abstract][Full Text] [Related]
28. Anxiety: its generation by drugs and by their withdrawal.
Dorow R; Duka T
Adv Biochem Psychopharmacol; 1986; 41():211-25. PubMed ID: 2874694
[No Abstract] [Full Text] [Related]
29. Anxiolytic-like activity of SB-205384 in the elevated plus-maze test in mice.
Navarro JF; Burón E; Martín-López M
Psicothema; 2006 Feb; 18(1):100-4. PubMed ID: 17296016
[TBL] [Abstract][Full Text] [Related]
30. Animal models for predicting clinical efficacy of anxiolytic drugs: social behaviour.
File SE
Neuropsychobiology; 1985; 13(1-2):55-62. PubMed ID: 2863779
[TBL] [Abstract][Full Text] [Related]
31. Anxiolytic activity of melatonin in mice: involvement of benzodiazepine receptors.
Pierrefiche G; Zerbib R; Laborit H
Res Commun Chem Pathol Pharmacol; 1993 Nov; 82(2):131-42. PubMed ID: 7905658
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors.
Cox ED; Diaz-Arauzo H; Huang Q; Reddy MS; Ma C; Harris B; McKernan R; Skolnick P; Cook JM
J Med Chem; 1998 Jul; 41(14):2537-52. PubMed ID: 9651158
[TBL] [Abstract][Full Text] [Related]
33. [A pharmaco-ethological study of the GABA-ergic mechanisms regulating the depression-like behavior of mice].
Belozertseva IV; Andreev BV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1997; 47(6):1024-31. PubMed ID: 9472168
[TBL] [Abstract][Full Text] [Related]
34. Triazolobenzodiazepines antagonize the effects of anxiogenic drugs mediated at three different central nervous system sites.
File SE; Pellow S
Neurosci Lett; 1985 Oct; 61(1-2):115-9. PubMed ID: 2867497
[TBL] [Abstract][Full Text] [Related]
35. Anxiolytic activity on locus coeruleus-mediated suppression of muricidal aggression.
Kozak W; Valzelli L; Garattini S
Eur J Pharmacol; 1984 Oct; 105(3-4):323-6. PubMed ID: 6150860
[TBL] [Abstract][Full Text] [Related]
36. Balance control and posture differences in the anxious BALB/cByJ mice compared to the non anxious C57BL/6J mice.
Lepicard EM; Venault P; Perez-Diaz F; Joubert C; Berthoz A; Chapouthier G
Behav Brain Res; 2000 Dec; 117(1-2):185-95. PubMed ID: 11099772
[TBL] [Abstract][Full Text] [Related]
37. Abecarnil is a full agonist at some, and a partial agonist at other recombinant GABAA receptor subtypes.
Pribilla I; Neuhaus R; Huba R; Hillmann M; Turner JD; Stephens DN; Schneider HH
Psychopharmacol Ser; 1993; 11():50-61. PubMed ID: 7908433
[No Abstract] [Full Text] [Related]
38. Aggression, anxiety and vocalizations in animals: GABAA and 5-HT anxiolytics.
Miczek KA; Weerts EM; Vivian JA; Barros HM
Psychopharmacology (Berl); 1995 Sep; 121(1):38-56. PubMed ID: 8539340
[TBL] [Abstract][Full Text] [Related]
39. Anxiolytic drug targets: beyond the usual suspects.
Gordon JA
J Clin Invest; 2002 Oct; 110(7):915-7. PubMed ID: 12370268
[No Abstract] [Full Text] [Related]
40. [Benzodiazepines, receptor affinity, their endogenous ligands and the modeling of new psychotropic preparations].
Voronina TA; Andronati SA; Akhundov RA; Chepelev VM
Vestn Akad Med Nauk SSSR; 1984; (11):13-20. PubMed ID: 6152097
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
